Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Inventory
Raw materials, work in progress, and finished goods held for sale.
Beta Bionics, Inc.NASDAQ: BBNX
Inventory · Q1 FY2026 · quarter ended Mar 2026
Inventory rises 50.8% from a year ago
Inventory stood at $23.73M at the end of Q1 FY2026, up 50.8% from a year earlier and up 9.2% from the prior quarter.
Context
- Inventory amounted to 7.8% of total assets at the end of Q1 FY2026, up 3.1 pp from a year earlier.
- Inventory increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether inventory keeps rising in the next quarterly balance sheet after a +50.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Inventory history
USD · from the balance sheet
- Latest · FY2025
- 21.72M USD
- Year-over-year change
- +63.1%
| Period | Period end | Inventory | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.72M | +63.1% |
| FY2024 | 2024-12-31 | 13.32M | +969.9% |
| FY2023 | 2023-12-31 | 1.25M | — |
| FY2022 | 2022-12-31 | 0 | — |
Inventory vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so inventory is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +50.8% is the 2nd highest of 6, against a peer median of +12.5%.
- Inventory amounts to 7.8% of total assets for BBNX, versus a peer median of 8.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 51.35B DKK | +12.5% | +26.7% | 8.6% | |
| Jun 2026 | $726.4M USD | +27.3% | +27.1% | 11.3% | |
| Jun 2026 | $484.8M USD | +8.5% | +9.3% | 15.3% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $356M USD | — | — | 7.5% |
| Mar 2026 | $126.4M USD | -10.5% | +5.0% | 11.0% | |
| Mar 2026 | $49.17M USD | +70.2% | +17.5% | 6.6% | |
| Mar 2026 | $23.73M USD | +50.8% | — | 7.8% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding BBNX) | — | +12.5% | +17.5% | 8.6% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.